Takeda's Commitment to Diversity in Clinical Research

This document is a guide detailing Takeda's commitment to diversity, equity, and inclusion (DE&I) in clinical research. It outlines the company's objective to achieve health equity by addressing disparities that affect underserved communities, particularly in clinical trial participation. The guide emphasizes the importance of including diverse patient populations in clinical trials to ensure reliable data and effective treatments. It describes Takeda's community engagement strategies, which involve partnerships with local organizations to enhance awareness and education about clinical research. The document also presents the company's P.A.V.E. strategy, which focuses on partnering with community stakeholders, enhancing site diversity, verifying inclusion goals, and addressing barriers to patient access. Additionally, it highlights efforts to develop educational resources and tools to support these initiatives, ensuring that clinical trials reflect the diverse populations they aim to serve. Overall, the guide emphasizes the need for a global perspective on DE&I in clinical research.